Ataluren for treating Duchenne muscular dystrophy with a nonsense mutation in the dystrophin gene

  • Highly specialised technologies guidance
  • HST22
  • Published: 

Evidence

Documents containing the evidence that was used to develop the recommendations.

Supporting evidence